Prevention of venous thrombosis over the lower limbs after total hip arthroplasty by utilization of pneumatic therapy in addition to rivaroxaban

被引：1
|
作者：
Wei, Fengai [1 ]
Bang, Chen [2 ]
Zhang, Jing [3 ]
机构：
[1] Lanzhou Univ, Hosp 2, Dept Anesthesia, Operating Room, Lanzhou 730030, Peoples R China
[2] Jianghan Oilfield Gen Hosp, Dept Intens Care Unit, Qianjiang 430064, Peoples R China
[3] Cent Hosp Enshi Tujia & Miao Autonomous, Dept Anesthesiol, Enshi 445000, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2021年 / 44卷 / 09期
关键词：
Hip arthroplasty; Venous thromboembolism; Rivaroxaban; Intermittent pneumatic therapy;
D O I：
10.1016/j.asjsur.2021.06.022
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：1222 / 1223
页数：2
相关论文
共 43 条
  • [21] The Utilization of Postoperative Inpatient Ultrasound for Lower Extremity Deep Venous Thrombosis Following Total Hip Arthroplasty has Decreased Dramatically Over the Past Decade With No Obvious Negative Impact on Patient Care
    Sequeira, Sean B.
    Kamalapathy, Pramod N.
    Burke, John F.
    Hughes, Garrison
    Browne, James A.
    JOURNAL OF ARTHROPLASTY, 2022, 37 (10): : 2071 - 2075
  • [22] Low-molecular-weight heparin followed by rivaroxaban or not for the prevention of deep venous thromboembolism after total knee arthroplasty
    Zhou, Jian
    Fang, Rui
    Yan, Qian
    Li, Chenxi
    Zhou, Yanlin
    Nur, Ayub Abdulle
    Liu, Tang
    Wang, Wanchun
    BLOOD COAGULATION & FIBRINOLYSIS, 2019, 30 (01) : 29 - 33
  • [23] Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty
    Zou, Yue
    Tian, Shaoqi
    Wang, Yuanhe
    Sun, Kang
    BLOOD COAGULATION & FIBRINOLYSIS, 2014, 25 (07) : 660 - 664
  • [24] Efficacy and safety of aspirin and rivaroxaban for venous thromboembolism prophylaxis after total hip or knee arthroplasty A protocol for meta-analysis
    Le, Guoping
    Yang, Chengzhi
    Zhang, Ming
    Xi, Licheng
    Luo, Hanwen
    Tang, Jingli
    Zhao, Jinmin
    MEDICINE, 2020, 99 (49) : E23055
  • [25] Cost-effectiveness of rivaroxaban versus heparins for prevention of venous thromboembolism after total hip or knee surgery in Sweden
    Ryttberg, Lars
    Diamantopoulos, Alex
    Forster, Fiona
    Lees, Michael
    Fraschke, Anina
    Bjorholt, Ingela
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2011, 11 (05) : 601 - 615
  • [26] A RCT study of Rivaroxaban, low-molecular-weight heparin, and sequential medication regimens for the prevention of venous thrombosis after internal fixation of hip fracture
    Tang, Yilun
    Wang, Kunzheng
    Shi, Zhibin
    Yang, Pei
    Dang, Xiaoqian
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 92 : 982 - 988
  • [27] The efficacy and cost-effectiveness of enoxaparin versus rivaroxaban in the prevention of venous thromboembolism following total hip or knee arthroplasty: A meta-analysis
    Xu, Joshua
    Chang, David
    Chui, Juanita
    Cao, Jacob
    Negus, Jonathan
    JOURNAL OF ORTHOPAEDICS, 2022, 30 : 1 - 6
  • [28] Pharmacoeconomic Evaluation of Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement in Spain
    Antonio Gómez-Outes
    Cristina Avendaño-Solá
    Ana Isabel Terleira-Fernández
    Emilio Vargas-Castrillón
    PharmacoEconomics, 2014, 32 : 919 - 936
  • [29] Ranking the efficacy of anticoagulants for the prevention of venous thromboembolism after total hip or knee arthroplasty: A systematic review and a network meta-analysis
    Feng, Weili
    Wang, Xiaoping
    Huang, Daoqiang
    Lu, Anqi
    PHARMACOLOGICAL RESEARCH, 2021, 166
  • [30] Postoperative prophylactic effect of fondaparinux for prevention of deep venous thrombosis after cemented total hip replacement: a comparative study
    Kawaji, Hiroyuki
    Ishii, Masaji
    Tamaki, Yasunobu
    Hamasaki, Makoto
    Ishikawa, Hitoshi
    Sasaki, Kan
    Dairaku, Katsuyuki
    Takagi, Michiaki
    MODERN RHEUMATOLOGY, 2012, 22 (02) : 216 - 222
12345